|
1
|
René O, Fauber B, Boenig GL, Burton B, Eidenschenk C, Everett C, Gobbi A, Hymowitz SG, Johnson AR, Kiefer JR, Liimatta M, Lockey P, Norman M, Ouyang W, Wallweber HA, Wong H. Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action. ACS Med Chem Lett 2015; 6:276-81. [PMID: 25815138 PMCID: PMC4360161 DOI: 10.1021/ml500420y] [Citation(s) in RCA: 67] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2014] [Accepted: 12/04/2014] [Indexed: 12/21/2022] Open
Abstract
A minor structural change to tertiary sulfonamide RORc ligands led to distinct mechanisms of action. Co-crystal structures of two compounds revealed mechanistically consistent protein conformational changes. Optimized phenylsulfonamides were identified as RORc agonists while benzylsulfonamides exhibited potent inverse agonist activity. Compounds behaving as agonists in our biochemical assay also gave rise to an increased production of IL-17 in human PBMCs whereas inverse agonists led to significant suppression of IL-17 under the same assay conditions. The most potent inverse agonist compound showed >180-fold selectivity over the ROR isoforms as well as all other nuclear receptors that were profiled.
Collapse
Affiliation(s)
- Olivier René
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | - Benjamin
P. Fauber
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | | | - Brenda Burton
- Argenta, Early
Discovery, Charles River, 7-9 Spire
Green Centre, Flex Meadow, Harlow, Essex CM19 5TR, U.K.
| | - Céline Eidenschenk
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | - Christine Everett
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | - Alberto Gobbi
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | - Sarah G. Hymowitz
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | - Adam R. Johnson
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | - James R. Kiefer
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | - Marya Liimatta
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | - Peter Lockey
- Argenta, Early
Discovery, Charles River, 7-9 Spire
Green Centre, Flex Meadow, Harlow, Essex CM19 5TR, U.K.
| | - Maxine Norman
- Argenta, Early
Discovery, Charles River, 7-9 Spire
Green Centre, Flex Meadow, Harlow, Essex CM19 5TR, U.K.
| | - Wenjun Ouyang
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | - Heidi A. Wallweber
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| | - Harvey Wong
- Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States
| |
Collapse
|
|
2
|
Fang G, Maurer T, Garrenton L, Skelton N, Fauber B, Malek S, Giannetti A, Jackson P, Rudolph J, Wang W. Drugging the Undruggable Small-molecule Inhibition of Ras Oncoprotein. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)70114-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|